Zhongchao Inc.
ZCMD Healthcare Health Information Services
Zhongchao Inc.’s revenue for fiscal 2025 (year ended December 2025) was $11.4 million, down 28.3% from fiscal 2024.
Follow ZCMD
Zhongchao Inc. (ZCMD) EV/Sales
As of 16 October 2026, Zhongchao Inc. (ZCMD) trades at a EV/Sales of −0.4×. Over the past ten years it has ranged from −0.5× (June 2021) to 0.0× (December 2020); the current reading is higher than 35% of that period. That is below the Health Information Services industry median of 2.6× and below the Healthcare sector median of 3.4×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2025 | −0.4× | — |
| FY2024 | −0.4× | — |
| FY2023 | −0.4× | — |
| FY2022 | −0.4× | — |
| FY2021 | −0.4× | — |
| FY2020 | −0.5× | — |
| FY2019 | 0.0× | — |
| FY2018 | 0.0× | — |
| FY2017 | 0.0× | — |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Jun 2023 | 7,215× | (1.36%) |
| Dec 2022 | 7,314× | (3.41%) |
| Jun 2022 | 7,572× | (21.42%) |
| Dec 2021 | 9,637× | (2.59%) |
| 5 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| ACON Aclarion, Inc. compare | −137× |
| HLTHQ Cue Health Inc. compare | −1.1× |
| ZCMD Zhongchao Inc. | −0.4× |
| ETAOF ETAO International Co., Ltd. compare | n/m |
| VSEED VSee Health, Inc. compare | 0.2× |
| HCTI Healthcare Triangle, Inc. compare | 0.4× |
| RNLXY Renalytix plc - Sponsored ADR compare | 2.5× |
| BFRG Bullfrog AI Holdings Inc. compare | 7.0× |
| MGRX Mangoceuticals, Inc. compare | 15.6× |
| Health Information Services industry median | 2.6× |
| Healthcare sector median | 3.4× |
| Market median | 2.1× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)